French adults with incurable illnesses that cause unbearable pain now have a legal path to end their lives, after the country’s highest constitutional authority approved the measure and the text was published in the official journal. Framed in Paris as a law on “end of life” or “aid in dying,” the statute joins France with the Netherlands, Belgium, Switzerland and Canada as countries that allow the practice under defined conditions.
The law applies to patients of legal age who are French nationals or long-term residents, and it sets out a layered process. A doctor must first confirm eligibility, a medical panel then assesses whether the statutory criteria are met, and patients face a minimum two-day reflection period before the procedure can proceed, with a final confirmation required on the day. Patients may withdraw consent at any time, and they must self-administer the lethal substance unless they are physically unable to do so, in which case a healthcare professional may assist.
Until now France permitted passive measures such as withholding life-support and deep sedation at the end of life, but people seeking active options often travelled abroad. The law’s author, a centrist member of parliament, described the measure as “a major step forward.” President Emmanuel Macron, who pledged a right-to-die law during his 2022 re-election campaign, welcomed the approval and said it “concludes an exemplary democratic debate.” His office added the measure offers “an essential guarantee for our fellow citizens” and that it could now be implemented “in the certainty that it rests on fully established democratic, ethical and constitutional foundations.”
The constitutional council upheld the law in full, while ordering clarifications on several points. It required doctors to take account of patients’ legal guardians when assessing requests, and extended the right to refuse participation to pharmacists as well as doctors and nurses. The council also said the conscience clause must apply to private, often faith-based health facilities where assisted dying is “manifestly contrary” to their mission, provided they are not the sole establishments able to meet “local needs.”
Opponents reacted strongly. The Jérôme Lejeune Foundation, which provides lifetime care to people with genetic intellectual disabilities such as Down’s syndrome, expressed “outrage,” and other campaigners warned the measure posed “an absolute danger to the most vulnerable.” All members of parliament were allowed a free vote during parliamentary debate, reflecting the law’s sensitive ethical and social implications.
With constitutional challenges settled and procedural safeguards specified, the government can move toward implementation under the council’s clarifications. The law reshapes France’s approach to end-of-life care by creating a regulated, state-recognised option for a narrow group of patients, while leaving open contentious questions about protection for vulnerable populations and conscience rights for providers.
